← board
SNDL
distress 0/10 · well-funded / low risk$1.26-1%today-55% from 52w high
Revenue
$196M
Liquidity
$638M
Runway
—
Shares 1y
0%
Price & events
-22.7% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.8%
1D
-2.3%
1W
-11.9%
1M
-17.6%
3M
-23.2%
6M
-21.3%
1Y
-45.0%
2Y
-84.2%
5Y
-77.1%
All
Overview
- Market Cap
- $331.83M
- Volume
- 133.41K
- 52 Week Range
- $1.26 – $2.81
- Total Shares
- 263.36M
- Float Shares
- 225.82M
- Short %
- 0.72%
- % Held by Insiders
- 4.31%
- % Held by Institutions
- 22.13%
- RVOL
- 0.07x
- Beta
- 0.92
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-07-28earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 263,359,123 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2025-09-03Alliance Global PartnersBuy
Competitors
- none identified
Recent news
- 2026-07-23Earnings Preview: SNDL Inc to Report Financial Results Pre-market on July 28 - 富途牛牛
- 2026-07-22Does SNDL Inc (NASDAQ:SNDL) Stand Apart As Cannabis Trading Turns Active? - Kalkine Media
- 2026-07-21SNDL Q2'26 Earnings: revenue estimate is 166.26M USD - TradingView
- 2026-07-17What Sets SNDL (NASDAQ:SNDL) Apart Among Cannabis Stocks? - Kalkine Media
- 2026-07-15SNDL Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - Quiver Quantitative
- 2026-07-15SNDL Inc. (NASDAQ: SNDL) schedules Q2 2026 results and call - Stock Titan
- 2026-07-15SNDL to Report Second Quarter 2026 Financial Results on July 28, 2026 - Yahoo Finance
- 2026-07-13Is SNDL Inc. (NASDAQ:SNDL) Still A Penny Stock To Watch? - Kalkine Media
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.